Skip to main content

Table 2 Hazard ratios for mortality up to day 90

From: Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation

 

90-day mortality rate

Unadjusted

Events, n (%)

HR (95% CI)

 Erythromycin (n = 235)

76 (33.3%)

0.91 (0.69–1.19)

 Controls (n = 470)

167 (36.8%)

1.00 (ref)

PS matched

 Erythromycin (n = 211)

67 (32.8%)

0.89 (0.64–1.24)

 Controls (n = 211)

74 (36.6%)

1.00 (ref)

PS weighted

Events, %

 

 Erythromycin

34.6%

0.95 (0.66–1.36)

 Controls

37.3%

1.00 (ref)

  1. CI confidence interval, HR hazard ratio, IPTW inverse probability of treatment weighting, PS propensity score, ref referent
Back to article page

Critical Care

ISSN: 1364-8535